Combinations of valsartan with cox-2 inhibitors
CA 2506809 A1 · Owner: Novartis Ag · Inventors: Campion, Giles Victor; Plat, Francis R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates a pharmaceutical composition comprising a combination of (i) the AT 1- receptor blocker valsartan or a pharmaceutically acceptable salt thereof and (ii) a COX-2 inhibitor or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier and to a method for the treatment or prevention of a condition or disease selected from the group consisting of hypertension, heart failure such as (acute and chronic) congestive heart failure, left ventricular dysfunction and hypertrophic cardiomyopathy, diabetic cardiac myopathy supraventricular and ventricular , arrhythmias atrial fibrillation, atrial flutter, detrimental vascular remodeling, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 17, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 17, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 17, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.